While this major question cannot be exhausted in the scope of this current work, the data provided here show that FGF2 can efficiently disturb the homeostasis of cancer cells from different origin and phenotypes, increasing the toxicity of checkpoint and proteasome inhibitors. This evidence concerns the gene FGF2 and cancer.